Recruiting

Patient Decision Aid

Sponsor:

M.D. Anderson Cancer Center

Code:

NCT03892993

Conditions

Thyroid Gland Medullary Carcinoma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Accepted

Interventions

Decision Aid

Questionnaire Administration

Study Details

Brief summary:

This trial develops and studies how well a patient decision aid works in supporting decision-making about when to start or stop new drugs, join clinical trials, or continue active cancer monitoring for patients with medullary thyroid cancer and their caregivers. Developing a patient decision aid may help patients with medullary thyroid cancer make well-informed decisions about their cancer care and be able to discuss their preferences with their doctors.

Conditions

Thyroid Gland Medullary Carcinoma

Study ID

NCT03892993

Start date

Apr 9, 2019

Status verified date

Jul, 2026

Completion date

Aug 1, 2028

Anticipated

Primary completion date

Aug 1, 2028

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Accepted

Inclusion Criteria:

  • Aged 18 years old or older
  • Have or will face(d) this decision, including: Patient/survivor - who has medullary thyroid carcinoma, as determined by a clinician or documented in the Genetics of Endocrine Neoplasia Registry or sporadic (medullary thyroid carcinoma) MTC database; Caregiver/family member - of patient/survivor who has medullary thyroid carcinoma, as nominated by the patient/survivor; and Provider - who treats patients/survivors who have medullary thyroid carcinoma, as described above
  • Able to speak, read, and write English
  • Pregnant patients are included

Exclusion Criteria:

--Individuals with cognitive or psychological impairment (e.g., depression, anxiety, severe mental illness; as documented in the registry)

Study Design

Enrollment

120 participants

Anticipated

Intervention Model

Single group

Primary purpose

Supportive Care

Interventions and Outcome Measures

Arms

experimental: Supportive care (decision aid)

Participants use decision aid and complete questionnaires.

Interventions

Decision Aid

Use decision aid

Questionnaire Administration

Ancillary studies

Primary outcome measure

  • Needs assessment [ Time Frame: Up to 1 year ]
  • Decision aid design refining (storyboarding) [ Time Frame: Up to 1 year ]
  • Decision aid acceptability [ Time Frame: Up to 1 year post decision aid ]
  • Real World Evaluation [ Time Frame: Up to 1 year post ]

Central Contacts and Locations

Central contacts

Elizabeth G Grubbs, MD

(713) 792-0665eggrubbs@mdanderson.org

Locations

M D Anderson Cancer Center

Recruiting

Houston, Texas, United States, 77030

Contacts

Elizabeth G. Grubbs

713-792-6940eggrubbs@mdanderson.org

Principal Investigator:

Elizabeth G. Grubbs

More Information

Sponsor

M.D. Anderson Cancer Center

Last update posted

Jul 16, 2026

Last verified

Jul, 2026

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-09. This information was provided to ClinicalTrials.gov by M.D. Anderson Cancer Center on 2026-07-16.